Showing results (701-710 of 1,402) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|December 30, 2020
Therapeutic approaches against coronaviruses acute respiratory syndromeCamilla Servidio, Francesco StellacciPharmacology Research & Perspectives|January 2, 2020
Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT1 and MT2 receptorsCéline Legros, Clémence Dupré, Chantal Brasseur, et al.Pharmacology Research & Perspectives|January 1, 2020
The awareness of the Jordanian population about OTC medications: A cross-sectional studyEsra' Taybeh, Zina Al-Alami, Mervat Alsous, et al.Pharmacology Research & Perspectives|April 2, 2020
Active transport of rhodamine 123 by the human multidrug transporter P-glycoprotein involves two independent outer gatesFauzia Nasim, Diethart Schmid, Gergely Szakács, et al.Pharmacology Research & Perspectives|September 30, 2020
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat modelsMohamed El-Shabrawy, Amal Mishriki, Hisham Attia, et al.Pharmacology Research & Perspectives|October 30, 2020
Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infectionsSumonrat Chuwongwattana, Thawinee Jantararoungtong, Santirat Prommas, et al.Pharmacology Research & Perspectives|October 30, 2020
Nucleotide analogues as inhibitors of SARS-CoV PolymeraseJingyue Ju, Xiaoxu Li, Shiv Kumar, et al.Pharmacology Research & Perspectives|July 30, 2021
Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammationXiao-Fang Zheng, Dan-Dan Chen, Xiao-Ling Zhu, et al.Pharmacology Research & Perspectives|July 30, 2021
Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogsJorge Gomez-Galeno, Karl Okolotowicz, Mark Johnson, et al.Pharmacology Research & Perspectives|June 1, 2022
Involvement of β-adrenoceptors in the cardiovascular responses induced by selective adenosine A2A and A2B receptor agonistsEdward S Wragg, Patrizia Pannucci, Stephen J Hill, et al.Pageof 141